U.S. News

Drugmakers Are Turning Patients With Rare Diseases Into D.C. Lobbyists

‘Tricks of the Trade’

Patients with the rarest afflictions are being trained as powerful advocates on Capitol Hill for new drugs and legislation that would help the industry.

KFF Health News
KFF Health News
articles/2017/04/10/drugmakers-are-turning-patients-with-rare-diseases-into-d-c-lobbyists/170410-kaiser-health-lobbyists-diseases-tease_zpsbmq
Photo Illustration by Elizabeth Brockway/The Daily Beast
KFF Health News

KFF Health News

maryagnesc@kff.org

Got a tip? Send it to The Daily Beast here.

Trending Now
PoliticsElon Musk Dramatically Puts MAGA Split With RFK Jr. on Display
David Gardner
WorldFallen Syrian Dictator’s Wife Said to Be Fighting for Life
Hugh Dougherty
PoliticsTrump’s DOGE Guy Sparks MAGA Civil War With Slam on American Culture
Josh Fiallo
RoyalistRoyals’ Walk to Christmas Service Reveals Deep Family Dysfunction
Tom Sykes
PoliticsChuck Schumer Reveals Stealth Dem Plan to Block MAGA Revolution
David Gardner